Jiangsu Hengrui Medicine
600276.SS
#431
Rank
HK$438.50 B
Marketcap
HK$66.07
Share price
1.65%
Change (1 day)
38.12%
Change (1 year)
Jiangsu Hengrui Medicine Company Limited is a Chinese pharmaceutical company engaged in the R&D, manufacturing and sales of healthcare products, including antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents and antibiotics

Half-year Reports

Thumbnail Jiangsu Hengrui Medicine
 Half-year Report 2025-h1

Half-year Report 2025-h1

Language: Chinese

View Half-year Report